NCT02139592
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Osaka, Japan
Clinical trial condition
Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
Explore clinical trials studying Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies